(medetomidine and vatinoxan hydrochlorides injection)
Zenalpha® features a unique mechanism of action that helps minimize cardiovascular effects. Medetomidine is an alpha-2 agonist responsible for sedative and analgesic properties whereas Vatinoxan is an alpha-2 antagonist, acting in the periphery without crossing the blood-brain barrier. Dogs should be monitored frequently during sedation for changes in heart rate, blood pressure, respiratory rate and body temperature.
For more information, visit www.Zenalpha.us.
Zennovation in Sedation
Start Here
to receive more information